Editorial: Current trends in immunotherapy: from monoclonal antibodies to CAR-T cells

Editorial: Current trends in immunotherapy: from monoclonal antibodies to CAR-T cells

Saved in:

Bibliographic Details
Main Authors:	Kishor Pant, Mark C. Glassy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Molecular Medicine
Subjects:	immunotherapy monoclonal antibodies CAR-T cells cancer therapy targeted therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmmed.2025.1633469/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CD70 as a target in cancer immunotherapy: advances, challenges, and future directions
by: Ruchen Wu, et al.
Published: (2025-08-01)

Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
by: Rose Ghemrawi, et al.
Published: (2024-09-01)

Emerging strategies to overcome ovarian cancer: advances in immunotherapy
by: Tatiana Massariol Pimenta, et al.
Published: (2024-11-01)

Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas
by: Michael J. Robertson, et al.
Published: (2025-06-01)

CAR-T cell therapy in china: innovations, challenges, and strategic pathways
by: Lihui Yan, et al.
Published: (2025-08-01)

A hexamerization-enhanced, Fc-silenced agonistic CD27 antibody amplifies T-cell effector functions as single agent and in combination with PD-1 blockade
by: Işıl Altıntaş, et al.
Published: (2025-07-01)

Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches
by: Daouda Abba Moussa, et al.
Published: (2025-12-01)

Development and Characterization of 4A7: A High-Affinity Monoclonal Antibody Targeting Claudin18.2
by: Wu Y, et al.
Published: (2025-03-01)

11th Immunotherapy of Cancer conference (ITOC): A meeting report
by: Stefanos Michaelides, et al.
Published: (2025-12-01)

Production and application of monoclonal antibodies to GST
by: WU Jian-xiang, et al.
Published: (2006-07-01)

Precision sniper for solid tumors: CAR-NK cell therapy
by: Sisi Li, et al.
Published: (2025-07-01)

Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
by: Ruili Wang, et al.
Published: (2025-04-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
by: A. V. Onyan, et al.
Published: (2016-02-01)

CAR-iNKT cells: redefining the frontiers of cellular immunotherapy
by: Magdalena Niedzielska, et al.
Published: (2025-07-01)

“A.B.C.” of Immunotherapy in Hematological Malignancies…Promise and Perils
by: Jyoti Bajpai, et al.
Published: (2024-04-01)

Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01)

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
by: Tao Wang, et al.
Published: (2025-07-01)

CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors
by: Yunjia Xian, et al.
Published: (2025-06-01)

Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers
by: Huaizhi Chen, et al.
Published: (2025-06-01)

Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA
by: Maryam Monajati, et al.
Published: (2024-09-01)

Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma
by: L. V. Bolotina, et al.
Published: (2022-04-01)

Targeted fusion of antibody-secreting cells: Unlocking monoclonal antibody production with hybridoma technology
by: Fanny Rousseau, et al.
Published: (2025-12-01)

A combination of two human monoclonal antibodies cures symptomatic rabies
by: Guilherme Dias de Melo, et al.
Published: (2020-09-01)

Nanobodies and their derivatives: pioneering the future of cancer immunotherapy
by: Haixia Li, et al.
Published: (2025-06-01)

Bevacizumab—Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment
by: Razvan Constantin Vonica, et al.
Published: (2025-03-01)

CAR-NK cell therapy: promise and challenges in solid tumors
by: Sahar Balkhi, et al.
Published: (2025-04-01)

Current trends and future of gene-cell immunotherapy in the treatment of HIV infection
by: A. P. Faenko, et al.
Published: (2025-05-01)

Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery
by: Elnazalsadat Jafarzadeh Chehraghi, et al.
Published: (2025-04-01)

The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies
by: Ping Wang, et al.
Published: (2024-11-01)

CAR-T Cell Therapy: Managing Side Effects and Overcoming Challenges
by: Maryam Golmohammadi, et al.
Published: (2025-04-01)

Production and identification of monoclonal antibodies to chCD25
by: WU Wei, et al.
Published: (2007-09-01)

Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances
by: Dong Xie, et al.
Published: (2025-04-01)

Editorial: Immunotherapy resistance and advancing adaptive cell therapeutics
by: Luciana Rodrigues Carvalho Barros, et al.
Published: (2025-06-01)

Global Market of Monoclonal Antibodies: Sales, Prices, Demand
by: D. A. Uvarov
Published: (2021-04-01)

Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
by: Maowu Fu, et al.
Published: (2025-03-01)

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
by: Safwaan H. Khan, et al.
Published: (2025-01-01)

Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody
by: Isabella Hrabal, et al.
Published: (2025-03-01)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)

Depletion-restitution therapy for autoimmune rheumatic diseases. Part 1. Fundamental prerequisites and efficacy of modern treatment technologies: anti-B-cell drugs and CAR-T therapy
by: A. M. Lila, et al.
Published: (2025-04-01)

Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies
by: A. L. Maslyanskiy, et al.
Published: (2025-06-01)